The goal of this program is to improve management of cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC). After hearing and assimilating this program, the clinician will be better able to:Evaluate the efficacy of adjuvant therapy and chemotherapy in the management of CCA.Analyze the efficacy of biologic therapies targeting IDH1 and FGFR2 alterations in CCA.Describe locoregional and systemic therapies for the management of HCC.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2023-08-24 05:00:00
- End Date: 2023-08-24 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest